Ehrlichia Chaffeensis (IgG, IgM)

Serum

Performed by: Quest Diagnostics

The Ehrlichia Chaffeensis (IgG, IgM) panel is a critical diagnostic tool used for detecting Ehrlichiosis, a bacterial illness transmitted by ticks. This panel tests for both IgG and IgM antibodies against Ehrlichia chaffeensis, the bacterium responsible for the disease. The presence of IgM antibodies typically indicates a recent or acute infection, as these are the first antibodies to be produced in response to an infection. IgG antibodies, on the other hand, develop more slowly and can indicate a past infection or a more chronic stage of the disease. This dual testing approach allows for a comprehensive assessment of the infection's timeline, aiding in the accurate diagnosis and appropriate treatment planning. Ehrlichiosis can cause flu-like symptoms and, if left untreated, may lead to severe complications. Therefore, the Ehrlichia Chaffeensis (IgG, IgM) panel is essential for timely identification and management of the infection, particularly in areas where tick-borne diseases are prevalent. The test plays a significant role in enhancing patient care by facilitating early detection and intervention, underscoring the importance of accurate diagnostic tools in infectious disease management.

Biomarkers included in this panel:

E. CHAFFEENSIS AB IGG

The E. Chaffeensis Ab IgG test is a specialized diagnostic tool pivotal in the field of infectious diseases, particularly in the context of tick-borne illnesses. Ehrlichia chaffeensis is the bacterium responsible for Ehrlichiosis, a condition transmi

Learn more

E. CHAFFEENSIS AB IGM

The E. Chaffeensis Ab IgM test is a crucial diagnostic tool in the realm of infectious diseases, specifically for the timely detection of Ehrlichiosis, a tick-borne illness caused by the Ehrlichia chaffeensis bacterium. This test detects IgM antibodi

Learn more